Pharma-Bio Serv, Inc. (PBSV) stock
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Pharma-Bio Serv gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Pharma-Bio Serv's gross profit for the twelve months ending Jul 31, 2026 was $3.07M, up 6.1% year over year. For fiscal 2025 it was $2.91M, up 15.7% from the year before. Over ten years it grew -9.0% a year on average. The highest annual figure on record is $11.83M in fiscal 2013.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $2.91M | +15.7% |
| FY2024 | Oct 31, 2024 | $2.52M | -50.3% |
| FY2023 | Oct 31, 2023 | $5.07M | +3.8% |
| FY2022 | Oct 31, 2022 | $4.88M | -8.9% |
| FY2021 | Oct 31, 2021 | $5.36M | -19.6% |
| FY2020 | Oct 31, 2020 | $6.67M | +7.9% |
| FY2019 | Oct 31, 2019 | $6.18M | +8.6% |
| FY2018 | Oct 31, 2018 | $5.69M | +48.0% |
| FY2017 | Oct 31, 2017 | $3.84M | -33.6% |
| FY2016 | Oct 31, 2016 | $5.78M | -22.7% |
| FY2015 | Oct 31, 2015 | $7.48M | -16.6% |
| FY2014 | Oct 31, 2014 | $8.97M | -24.2% |
| FY2013 | Oct 31, 2013 | $11.83M | +19.9% |
| FY2012 | Oct 31, 2012 | $9.87M | +43.9% |
| FY2011 | Oct 31, 2011 | $6.86M | +102.2% |
| FY2010 | Oct 31, 2010 | $3.39M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $691.73K | +20.5% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $902.04K | +10.2% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $722.37K | -6.0% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $748.94K | +3.1% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $574.26K | -9.6% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $818.73K | +32.4% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $768.11K | +43.4% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $726.57K | -21.9% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $635.38K | -59.0% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $618.48K | -54.1% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $535.61K | -56.8% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $929.81K | -75.4% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $1.55M | – |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $1.35M | -10.2% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $1.24M | -1.2% |
| Q1 FY2022CQ4 2021 | Jul 31, 2022 | $3.77M | +192.3% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | -$1.31M | -199.8% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $1.50M | +10.4% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $1.26M | -32.3% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $1.29M | -30.9% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $1.32M | -17.1% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $1.36M | -11.7% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $1.85M | +18.4% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $1.87M | +17.3% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $1.59M | +7.2% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $1.54M | -17.9% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $1.57M | -1.8% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $1.59M | +53.7% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $1.48M | +25.2% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $1.87M | +123.0% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $1.59M | +71.7% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $1.04M | -0.4% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $1.18M | +14.5% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $840.68K | -21.8% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $928.11K | -34.9% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $1.04M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $1.03M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $1.07M | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $1.43M | – |
See a number that looks wrong?